Clinical Trials Directory

Trials / Completed

CompletedNCT04340999

Electrophysiological Evaluation of Motor Dysfunction in Liver Cirrhotic Patients

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

cross sectional observational study, aimed to assess the electrophysiological function of the motor units in liver cirrhotic patients.

Detailed description

Liver cirrhosis is a global health problem which could be associated with several neurological manifestations. The associated peripheral neuropathy could be assessed by conventional nerve conduction studies. Objective: The study aims at early detection of peripheral neuropathy among patients of liver cirrhosis by conventional nerve conduction studies and quantitative EMG methods. In addition, the study aims at finding out correlation between peripheral neuropathy and severity of the liver cirrhosis. Methods: This a cross-sectional study conducted on fifty-six liver cirrhotic patients, that had been recruited from the Endemic medicine department/outpatient clinics and their age-gender matched sixty-one healthy controls. The recruited patients were clinically assessed .Both conventional nerve conduction studies and quantitative EMG techniques in the form of MUNE calculation, using modified spike -triggered technique and IPA ratio evaluation were performed for the allocated cirrhotic patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNerve conduction studies and Quantitative EMG ( MUNE and IPA)Nerve Conduction Studies: Electrophysiological method that tests the presence/absence of peripheral neuropathy. MUNE: Electrophysiological technique that assess number of motor units. IPA: Electrophysiological method that assess interference pattern and hence, borderline cases of neuropathy/ myopathy

Timeline

Start date
2018-08-01
Primary completion
2019-12-31
Completion
2020-03-05
First posted
2020-04-10
Last updated
2020-04-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04340999. Inclusion in this directory is not an endorsement.